Ipca Laboratories Ltd.
https://www.ipca.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Ipca Laboratories Ltd.
Ipca Strikes Biosimilar Technology Transfer Amid Rising Ambitions In The Space
Ipca Laboratories underlined its commitment to successfully developing quality and affordable biosimilars meeting global standards as it penned a technology transfer agreement with a fellow Indian firm.
Big Pharma Shouts, Generics And Biosimilars Whisper: M&A In 2023
“A lot of companies are hurting because of the higher interest rates,” one major CEO observed recently, summing up a year which saw little headline-grabbing news on the M&A front for generic and biosimilar sponsors.
Big Pharma Shouts, Generics And Biosimilars Whisper: M&A In 2023
“A lot of companies are hurting because of the higher interest rates,” one major CEO observed recently, summing up a year which saw little headline-grabbing news on the M&A front for generic and biosimilar sponsors.
Unichem Becomes A Part Of Ipca As Its Holding Moves Above 50%
Ipca Laboratories has completed an open offer for another slice of Unichem, following a recent deal to acquire a third of the company.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- Other Names / Subsidiaries
-
- Onyx Scientific Limited, Tonira Exports Limited, Covenance, etc
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice